Panel discussion.

12 More presentations in this session

Clinical effects of anacetrapib in people with established vascular disease: Results of the Randomized EValuation of the Effects of Anacetrapib through Lipid-modification (HPS3/TIMI55-REVEAL) trial

Professor M. Landray (Oxford, GB)

Slides Video

Discussant review: Clinical effects of anacetrapib in people with established vascular disease: Results of the Randomized EValuation of the Effects of Anacetrapib through Lipid-modification (HPS3/TIMI55-REVEAL) trial

Professor J. Chapman (Paris, FR)

Slides Video

Does intensive treat-to-target LDL-C lowering therapy using statin in patients of diabetic retinopathy reduce cardiovascular events?: the EMPATHY study

Professor H. Itoh (Tokyo, JP)

Slides Video

Discussant review: Does intensive treat-to-target LDL-C lowering therapy using statin in patients of diabetic retinopathy reduce cardiovascular events?: the EMPATHY study

Professor E. Prescott (Copenhagen, DK)

Slides Video

Panel discussion.

Video